The question is no longer whether AI will reshape your workforce. It already has. The harder question, and one most organizations have yet to solve is: how do you intentionally design how humans and AI work together to maximize value? Deloitte’s 2026 Global Human Capital Trends research reveals that while 60% of executives are already […]
This session showcases software companies using artificial intelligence, automation, and modern cloud platforms to solve real-world problems across healthcare, construction, education, finance, and beyond. What unites them is a commitment to replacing inefficiency with intelligence — and delivering measurable impact to the people and organizations they serve.
Most founders think fundraising is a pitch contest. It isn’t. It’s a structured process driven by preparation, evidence, and investor psychology. In this talk, Lesley Ross shares the playbook founders can use to navigate venture fundraising and significantly improve their odds of success.
We are excited to host an invite-only Tech Investor Lunch during Venture Connect. This is a unique opportunity to network with fellow tech investors over lunch and engage in insightful conversations. Thank you to KPMG for sponsoring this lunch!
Take a break, grab a bite, and connect organically with fellow attendees. This unscripted, unstructured lunch is your time to step outside, spark new conversations, and build relationships in a relaxed setting. Whether you're diving into a deep discussion or simply recharging for the afternoon sessions, this is your opportunity to network, unwind, and fuel […]
Launch Chapel Hill Powered by KPMG presents a live showcase of its inaugural cohort, featuring ten early stage AI and deeptech startups building technical, high impact solutions. Founders take the stage back to back in a fast moving session that offers a clear look at emerging technologies, bold ideas, and the next generation of companies […]
From ENT care to oncology, the companies in this session are redefining how medicine is practiced, delivered, and experienced. Whether through novel device engineering, AI-powered diagnostics, or breakthrough therapeutics, these innovators are tackling some of healthcare’s most persistent challenges.
The Triangle's next biotech companies are already taking shape in university labs. This session brings six faculty scientists to the stage to present discoveries at the frontier of venture formation — giving investors an early look at the human health innovations poised to anchor the Triangle's next wave of biotech companies.
Hear from our area's youngest entrepreneurs out of the NC School of Science and Mathematics who are designing solutions to tackle global challenges: Julianna Jones Anne Boafo Caroline Wang Lucas Rodriguez Chiappetta
The companies in this session are confronting some of the most pressing environmental and agricultural challenges of our time. From climate-resilient crops to next-generation water treatment and sustainable seafood, these innovators are using science to build a more resilient and sustainable world. Thank you, NCBiotech, for sponsoring this event.
Most founders think “lean” means hiring slowly and using ChatGPT on the side. That’s outdated. At Ariso, Erkang Zheng works with two “teammates” every day: Ari, an AI operating partner who handles the busywork and helps them grow, and Ivan, an AI engineering partner that ships code while we sleep. Together, they let them do […]
This session looks at how AI is actually being evaluated in life science today. Rather than focusing on hype or predictions, the conversation will explore what makes the technology credible, where it is genuinely useful, and why the companies gaining traction tend to be solving fundamental problems in ways that fit real scientific and industry […]